Journal of Biological Sciences1727-30481812-5719Asian Network for Scientific Information10.3923/jbs.2009.302.310Crocus sativus L. (Saffron) Stigma Ethanolic Extract on Rats with Alloxan-Induced Diabetes]]>MohajeriDaryoush MousaviGhafour DoustarYousef 4200994Adequate characterization of hypoglycemic effect of ethanolic saffron extract has not been yet done, though the activity has been reported. The scientific evaluation of its hypoglycemic activity was, therefore, explored and compared with the effect of a standard hypoglycemic drug, tolbutamide. In this study, we also report on alteration in patterns of pancreatic islet cells using histopathology and immunohistochemistry of alloxanized diabetic rats treated with ethanolic saffron extract. The ethanolic extract of Crocus sativus L. stigma was administered orally and intraperitoneally at different doses (20, 40 and 80 mg kg-1) to normal rats for finding the more effective hypoglycemic dose and administration route. Acute hypoglycemic effects produced by more effective dose of ethanolic saffron extract on the Fasting Blood Glucose (FBG) levels and effects of the same dose of ethanolic saffron extract on the FBG and plasma insulin levels in alloxanized Mild Diabetic (MD) and Severely Diabetic (SD) rats were assayed. Histopathological and immunohistochemical studies were also carried out on pancreatic islet cells of control and diabetic rats. The dose of 40 mg kg-1 was found to be more effective dose in intraperitoneally (i.p.) route for decreasing Blood Glucose Level (BGL). The extract administered by i.p. route at more effective dose showed an acute hypoglycemic effect in MD and SD rats. Treatment of MD and SD rats for 14 days with the more effective dose significantly reduced the FBG levels in these animals (41.4% MD, 30.7% SD). Serum insulin level showed significant increase in diabetic rats (33.3% MD, 27.3% SD) after 14 days. The histopathological studies of pancreas in ethanolic extract treated diabetic groups showed a reversed damage caused by alloxan to the pancreatic islets as almost normal appearance. In addition, diabetic (MD and SD) rats showed obvious decreases in insulin immunoreactivity and the number of β-cells in pancreas, but the pancreas of extract-treated diabetic rats was improved and the number of immunoreactive β-cells was significantly increased. The control group given saffron extract was not different from the other intact control group considering the insulin immunoreactivity in β-cells. The findings of present study indicate the hypoglycemic and potential antihyperglycemic nature of the extract, helping in regeneration of damaged pancreas in experimental diabetes. Thus, after randomized clinical trials, saffron extract may be implicated as a preventive or therapeutic agent against diabetes mellitus.]]>Achrekar, B., G.S. Kakij, M.S. Pote and S.M. Kelkar,19915143147Abdullaev, F.I.,2002Crocus sativus L.).]]>2272025Abe, K. and H. Saito,200014149152Akhtar, M.S. and J. Iqbal,1991314957Alarcon-Aguilara, F.J., R. Roman-Ramos, S. Perez-Gutierrez, A. Aguilar-Contreras, C.C. Contreras-Weber and J.L. Flores-Saenz,199861101110Alarcon-Aguilar, F.J., E. Hernandez-Galicia, A.E. Campos-Sepulveda, S. Xolalpa-Molina, J.F. Rivas-Vilchis, L.I. Vazquez-Carrillo and R. Roman-Ramos,2002Cucurbita ficifolia bouche (Cucurbitaceae) in different experimental models.]]>85185189Assimopoulou, A.N., Z. Sinakos and V.P. Papageorgiou,2005Crocus sativus L. extract and its bioactive constituents.]]>199971000Bailey, L.J. and C. Day,198912553564Boyle, J.P., A.A. Honrycult, K.M. Narayan, T.J. Hoerger, L.S. Geiss, H. Chen and T.J. Thompson, 20012419361940Eddouks, M., M. Maghrani, A. Lemhadri, M.L. Ouahidi and H. Jouad,20028297103El Daly, E.S.,1998Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats.]]>538793Giaccio, M.,200444155172Gupta, R.K., A.N. Kesari, P.S. Murthy, R. Chandra, V. Tandon and G. Watal,2005Annona squamosa L. in experimental animals.]]>997581Holman, R.R. and R.C. Turner,19911991pp: 467-469pp: 467-469Hosseinzadeh, H., H.R. Sadeghnia, T. Ziaee and A. Danaee,2005Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats.]]>8387393Ivorra, M.D., M. Paya and A. Villar,198927243275Jorns, A., M. Tiedge, S. Lenzen and R. Munday,1999in vitro.]]>2613001304Kesari, A.N., R.K. Gupta, S.K. Singh, S. Diwakar and G. Watal,2006107374379Kesari, A.N., R.K. Gupta and G. Watal,2005Murraya koenigii on normal and alloxan-diabetic rabbits.]]>97247251Kim, S.H., S.H. Hyun and S.Y. Choung,2006104119123Larner, J.,19851985pp: 149-151pp: 149-151Luo, J., D.M. Fort, T.J. Carlson, B.K. Noamesi and D. Nii-Amon-Kotei et al.,199815367374Maghrani, M., J.B. Michel and M. Eddouks,2005Retama raetam in rats.]]>19125128Marles, R.J. and N.R. Farnsworth,19952137189Minami, T., M. Shimizu, H. Tanaka, Y. Okazaki and M.G. Cherian,19991323341Rios, J.L., M.C. Recio, R.M. Giner and S. Manez,199610189193Sharma, S.R., S.K. Dwivedi, V.P. Varshney and D. Swarup,1996Aegle marmelos leaves in streptozotocin-diabetic rats.]]>10426428Sharma, S.R., S.K. Dwivedi and D. Swarup,199634372374Soeda, S., T. Ochiai, L. Paopong, H. Tanaka, Y. Shoyama and H. Shimeno,20016928872898Vanco, J.O. Svajlenova, E. Ramanska, J. Muselak and J. Valentova,200418155161Yang, Y.C., H.K. Hsu, J.H. Hwang and S.J. Hong,200319327333Hu, X., J. Sato, Y. Oshida, M. Xu, G. Bajotto and Y. Sato,200359103111Youn, J.Y., H.Y. Park and K.H. Cho,2004Commelina communis L.: Inhibition of α-glucosidase.]]>66S149S155